"Welcome to Digestive Disease Specialists Inc., where we specialize in the treatment of diseases of the gastrointestinal, or digestive, system. We are a collective of doctors and specialists serving the Edmond and OKC areas and aim to be the best gastroenterologists in the state. Our board-certified physicians and gastroenterologists use the latest diagnostic testing and techniques to provide our patients with the highest level of care possible. Our team is specifically focused on top gastrointestinal care, allowing us to offer our patients better information, better advice and better care than typical doctors."

During the past decade, Digestive Disease Specialists Inc conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 19 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 19 clinical trials were completed. i.e. 126.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Digestive Disease Specialists Inc" #1 sponsor was "Celgene" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Allergan" with 4 trials sponsored, "Abbott" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Digestive Disease Specialists Inc" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Digestive Disease Specialists Inc" are "Crohn Disease" (9 trials), "Ulcerative Colitis" (8 trials), "Crohn's Disease" (7 trials), "Colitis, Ulcerative" (4 trials) and "Gastroparesis" (4 trials). Many other conditions were trialed in "Digestive Disease Specialists Inc" in a lesser frequency.

Most popular intervention types in "Digestive Disease Specialists Inc" are "Drug" (35 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials), "Relamorelin" (3 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Disease Specialists Inc" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Disease Specialists Inc". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Digestive Disease Specialists Inc, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Disease Specialists Inc, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".